Key Financial Data Of Reporting Company

Fuso Pharmaceutical Industries,Ltd. - Filing #7594726

Concept As at
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
12,367,000,000 JPY
49,632,000,000 JPY
12,599,000,000 JPY
Ordinary profit (loss)
774,000,000 JPY
1,996,000,000 JPY
780,000,000 JPY
Profit (loss)
559,000,000 JPY
1,483,000,000 JPY
547,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
Total number of issued shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
Net assets
34,755,000,000 JPY
34,532,000,000 JPY
33,749,000,000 JPY
Total assets
71,474,000,000 JPY
69,334,000,000 JPY
69,686,000,000 JPY
Dividend paid per share
60.00
Basic earnings (loss) per share
63.76
169.09
62.45
Diluted earnings per share
Equity-to-asset ratio
0.486 xbrli:pure
0.498 xbrli:pure
0.484 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.